The first embryonic stem-cell derived therapy for the eye has been safely transplanted into two patients with no signs of inflammation, rejection or tumourigenicity, according to a report published online in The Lancet on 24 January 2012. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News
